Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
Recruiting · NCT07606352 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy | IgAN | Recruiting | Phase 2 | 2026-09-17 | NCT07606352 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sitala Bio LTD | 2 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Concord Hospital | Sydney | Australia | 1 |
| John Hunter Hospital | Newcastle | Australia | 14 |
| Nepean Hospital | Penrith | Australia | 2 |
| Prince of Wales Hospital | Sydney | Australia | 12 |
| Royal Perth Hospital | Perth | Australia | 43 |